BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 36094455)

  • 1. Is the world ready for the STICH 3.0 trial?
    Vervoort D; Jolicoeur ME; Marquis-Gravel G; Fremes SE
    Curr Opin Cardiol; 2022 Nov; 37(6):474-480. PubMed ID: 36094455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STICH3C: Rationale and Study Protocol.
    Fremes SE; Marquis-Gravel G; Gaudino MFL; Jolicoeur EM; Bédard S; Masterson Creber R; Ruel M; Vervoort D; Wijeysundera HC; Farkouh ME; Rouleau JL;
    Circ Cardiovasc Interv; 2023 Aug; 16(8):e012527. PubMed ID: 37582169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary revascularization for patients with severe left ventricular dysfunction.
    Nagendran J; Norris CM; Graham MM; Ross DB; Macarthur RG; Kieser TM; Maitland AM; Southern D; Meyer SR;
    Ann Thorac Surg; 2013 Dec; 96(6):2038-44. PubMed ID: 23968761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review.
    Deb S; Wijeysundera HC; Ko DT; Tsubota H; Hill S; Fremes SE
    JAMA; 2013 Nov; 310(19):2086-95. PubMed ID: 24240936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous coronary intervention vs. coronary artery bypass grafting for left main revascularization: an updated meta-analysis.
    Bajaj NS; Patel N; Kalra R; Marogil P; Bhardwaj A; Arora G; Arora P
    Eur Heart J Qual Care Clin Outcomes; 2017 Jul; 3(3):173-182. PubMed ID: 28838092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients with Left Ventricular Systolic Dysfunction.
    Khan MR; Kayani WT; Pelton J; Ansari A; Paniagua D; Khalid U; Denktas A; Changezi HU; Munir A; Jimenez E; Alam M; Jneid H
    Cardiovasc Drugs Ther; 2021 Jun; 35(3):575-585. PubMed ID: 32902738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment strategies in ischaemic left ventricular dysfunction: a network meta-analysis.
    Gaudino M; Hameed I; Khan FM; Tam DY; Rahouma M; Yongle R; Naik A; Di Franco A; Demetres M; Petrie MC; Jolicoeur EM; Girardi LN; Fremes SE
    Eur J Cardiothorac Surg; 2020 Oct; ():. PubMed ID: 33085752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.
    Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP
    J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes with percutaneous coronary revascularization vs coronary artery bypass grafting surgery in patients with unprotected left main coronary artery disease: A meta-analysis of 6 randomized trials and 4,686 patients.
    Palmerini T; Serruys P; Kappetein AP; Genereux P; Riva DD; Reggiani LB; Christiansen EH; Holm NR; Thuesen L; Makikallio T; Morice MC; Ahn JM; Park SJ; Thiele H; Boudriot E; Sabatino M; Romanello M; Biondi-Zoccai G; Cavalcante R; Sabik JF; Stone GW
    Am Heart J; 2017 Aug; 190():54-63. PubMed ID: 28760214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Current State of Left Main Percutaneous Coronary Intervention.
    Avula HR; Rassi AN
    Curr Atheroscler Rep; 2018 Jan; 20(1):3. PubMed ID: 29344756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Outcomes in Patients With Severely Reduced Left Ventricular Ejection Fraction Undergoing Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting.
    Sun LY; Gaudino M; Chen RJ; Bader Eddeen A; Ruel M
    JAMA Cardiol; 2020 Jun; 5(6):631-641. PubMed ID: 32267465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data.
    Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, Characteristics, Predictors, and Outcomes of Repeat Revascularization After Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting: The SYNTAX Trial at 5 Years.
    Parasca CA; Head SJ; Milojevic M; Mack MJ; Serruys PW; Morice MC; Mohr FW; Feldman TE; Colombo A; Dawkins KD; Holmes DR; Kappetein PA;
    JACC Cardiovasc Interv; 2016 Dec; 9(24):2493-2507. PubMed ID: 28007201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison on the long-term outcomes post percutaneous coronary intervention or coronary artery bypass grafting for bifurcation lesions in unprotected left main coronary artery].
    Yang BG; Yu XP; Chen F; Lyu SZ; Li Q; He JQ; Yuan F
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):19-25. PubMed ID: 28100341
    [No Abstract]   [Full Text] [Related]  

  • 15. Coronary artery bypass grafting vs. percutaneous coronary intervention for patients with three-vessel disease: final five-year follow-up of the SYNTAX trial.
    Head SJ; Davierwala PM; Serruys PW; Redwood SR; Colombo A; Mack MJ; Morice MC; Holmes DR; Feldman TE; Ståhle E; Underwood P; Dawkins KD; Kappetein AP; Mohr FW
    Eur Heart J; 2014 Oct; 35(40):2821-30. PubMed ID: 24849105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-Analysis Comparing Percutaneous Coronary Revascularization Using Drug-Eluting Stent Versus Coronary Artery Bypass Grafting in Patients With Left Ventricular Systolic Dysfunction.
    Cui K; Zhang D; Lyu S; Song X; Yuan F; Xu F; Zhang M
    Am J Cardiol; 2018 Nov; 122(10):1670-1676. PubMed ID: 30220418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does prior coronary angioplasty affect outcomes of surgical coronary revascularization? Insights from the STICH trial.
    Nicolau JC; Stevens SR; Al-Khalidi HR; Jatene FB; Furtado RHM; Dallan LAO; Lisboa LAF; Desvigne-Nickens P; Haddad H; Jolicoeur EM; Petrie MC; Doenst T; Michler RE; Ohman EM; Maddury J; Ali I; Deja MA; Rouleau JL; Velazquez EJ; Hill JA
    Int J Cardiol; 2019 Sep; 291():36-41. PubMed ID: 30929973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Left Ventricular Systolic Dysfunction: A Meta-Analysis.
    Zhang D; Lyu S; Song X; Yuan F; Xu F; Zhang M; Zhang M
    Angiology; 2017 Jan; 68(1):19-28. PubMed ID: 27069109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Revascularization in Patients With Multivessel Coronary Artery Disease and Severe Left Ventricular Systolic Dysfunction: Everolimus-Eluting Stents Versus Coronary Artery Bypass Graft Surgery.
    Bangalore S; Guo Y; Samadashvili Z; Blecker S; Hannan EL
    Circulation; 2016 May; 133(22):2132-40. PubMed ID: 27151532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous Coronary Intervention vs Coronary Artery Bypass Grafting in Patients With Left Main Coronary Artery Stenosis: A Systematic Review and Meta-analysis.
    Giacoppo D; Colleran R; Cassese S; Frangieh AH; Wiebe J; Joner M; Schunkert H; Kastrati A; Byrne RA
    JAMA Cardiol; 2017 Oct; 2(10):1079-1088. PubMed ID: 28903139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.